Effect of procathepsin D activation peptide on gene expression of breast cancer cells

被引:16
作者
Benes, Petr
Vashishta, Aruna
Saraswat-Ohri, Sujata
Fusek, Martin
Pospisilova, Sarka
Tichy, Boris
Vetvicka, Vaclav
机构
[1] Masaryk Univ, Fac Sci, Dept Genet & Mol Biol, CS-61137 Brno, Czech Republic
[2] Univ Louisville, Dept Pathol, Louisville, KY 40292 USA
[3] Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-10400 Prague, Czech Republic
[4] Univ Hosp Brno, Ctr Mol Biol & Gene Therapy, Dept Intenal Med Hematooncol, Brno, Czech Republic
关键词
breast cancer; gene expression; microarray analysis; procathepsin D;
D O I
10.1016/j.canlet.2005.07.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Overexpression of procathepsin D (pCD) is reported to occur in numerous types of cancer and is associated with increased growth and metastasis. It has been established that pCD affects multiple stages of tumor progression including proliferation, angiogenesis and metastasis. Previously, we showed that the mitogenic effect of pCD on cancer cells is mediated by interaction of its activation peptide (AP) with yet unidentified cell surface receptor. In this investigation, gene expression profiles were compared between AP-treated and control human breast cancer ZR-75-1 cells to elucidate the mechanism of AP mitogenicity. Several differentially expressed genes involved in signal transduction, regulation of cell cycle, apoptosis, tumor invasion and metastasis were identified using microarray technology. These findings, including overexpression of NF-kappa B2, were confirmed in breast cancer cell lines by reverse-transcriptase PCR (RT-PCR). Understanding the mechanism of pCDs effect on breast cancer cells could extend possibilities of breast cancer treatment in the future. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:46 / 54
页数:9
相关论文
共 48 条
[1]   NF-κB activation in cancer:: a challenge for ubiquitination- and proteasome-based therapeutic approach [J].
Amit, S ;
Ben-Neriah, Y .
SEMINARS IN CANCER BIOLOGY, 2003, 13 (01) :15-28
[2]   The Rho family GTPase Cdc42 regulates the activation of Ras/MAP kinase by the exchange factor Ras-GRF [J].
Arozarena, I ;
Aaronson, DS ;
Matallanas, D ;
Sanz, V ;
Ajenjo, N ;
Tenbaum, SP ;
Teramoto, H ;
Ighishi, T ;
Zabala, JC ;
Gutkind, JS ;
Crespo, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (34) :26441-26448
[3]   Cathepsin-D affects multiple tumor progression steps in vivo:: proliferation, angiogenesis and apoptosis [J].
Berchem, G ;
Glondu, M ;
Gleizes, M ;
Brouillet, JP ;
Vignon, F ;
Garcia, M ;
Liaudet-Coopman, E .
ONCOGENE, 2002, 21 (38) :5951-5955
[4]   Cysteine proteases as disease markers [J].
Berdowska, I .
CLINICA CHIMICA ACTA, 2004, 342 (1-2) :41-69
[5]   Nuclear factor-κB, cancer, and apoptosis [J].
Bours, V ;
Bentires-Alj, M ;
Hellin, AC ;
Viatour, P ;
Robe, P ;
Delhalle, S ;
Benoit, V ;
Merville, MP .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1085-1089
[6]   Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways [J].
Bouzahzah, B ;
Albanese, C ;
Ahmed, F ;
Pixley, F ;
Lisanti, MP ;
Segall, JD ;
Condeelis, J ;
Joyce, D ;
Minden, A ;
Der, CJ ;
Chan, A ;
Symons, M ;
Pestell, RG .
MOLECULAR MEDICINE, 2001, 7 (12) :816-830
[7]  
Brouillet JP, 1997, CANCER, V79, P2132, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2132::AID-CNCR10>3.3.CO
[8]  
2-L
[9]   Dying for NF-κB?: Control of cell death by transcriptional regulation of the apoptotic machinery [J].
Burstein, E ;
Duckett, CS .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (06) :732-737
[10]  
Chua SS, 2004, VITAM HORM, V68, P231